Alimera Sciences (ALIM) Misses Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Alimera Sciences (ALIM) Misses Q1 EPS by 3c

Alimera Sciences Reports First Quarter 2015 Financial Results

May 7, 2015 4:07 PM EDT

ATLANTA, May 7, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the first quarter ended March 31, 2015.

Dan Myers, president and chief executive officer of Alimera commented, "We launched ILUVIEN in the U.S. in the first quarter and our U.S. sales of ILUVIEN contributed over half of our total sales, demonstrating the significance of the U.S. market to our business. During this early stage of the... More